18/07/2025
🚨 BREAKING: COVID-19 mRNA Vaccine Linked to 8.4% Loss of Irreplaceable Corneal Cells in 75 Days!
A recent publication in ‘Ophthalmic Epidemiology’ reports concerning ocular effects from Pfizer’s BNT162b2 mRNA vaccine.
Key findings include:
• Study Population: 64 healthy adults (aged 18–45) evaluated before and 75 days after their first vaccine dose.
• Corneal Cell Loss: An 8.4% reduction in corneal endothelial cell density (from 2,797 to 2,563 cells/mm²).
• Corneal Thickening: A 7.6% increase in corneal thickness, indicating potential endothelial dysfunction.
• Mechanism: mRNA-induced spike protein and inflammatory responses may damage non-regenerative endothelial cells.
• Implications: Permanent cell loss may elevate risks of chronic corneal issues and vision impairment.
